Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old
- People who have had a diagnosis of migraine (with or without aura) for at least 1 year, based on established international headache diagnostic guidelines
- People with episodic migraine, meaning between 1 and fewer than 15 headache days per month, with at least 2 to 8 of those days having migraine features, for more than 3 months, and where the diagnosis was made before the age of 50
- People who have previously used or are currently using triptan medications to treat migraine attacks
- People who are able to speak and read Danish
Who may not be able to join:
- People who currently have chronic migraine, or who have had chronic migraine at any point in the last 12 months
- People who have other types of recurring headache conditions, apart from occasional tension-type headaches
- People whose headaches are caused by another underlying condition, including headaches caused by overusing pain or migraine medications
- People with severe psychiatric conditions, serious heart or blood vessel diseases, or severe liver disease
- People who have used opioid or barbiturate medications in the month before the screening visit
- People currently using certain prescription migraine prevention treatments, specifically botulinum toxin A injections or CGRP monoclonal antibody medications (note: stable use of some other migraine prevention medications, such as antidepressants, calcium channel blockers, beta blockers, or anti-epileptic drugs, may be permitted — confirm with trial site)
- People who are unable to tolerate triptans or for whom triptans are medically unsuitable
- People currently experiencing a substance use disorder
- People who have a metal or electronic device implanted in their head
- People who have a cardiac pacemaker, or an implanted or wearable defibrillator
- People who have used illegal psychotropic drugs within one week before the study, or who have used cannabis within four weeks before the study
- People who are currently pregnant, planning to become pregnant, or who are breastfeeding (pregnancy status is confirmed by a pregnancy test, and safe contraception as defined by the Danish Medicines Agency is required)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 4587165956
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Headache intensity; Adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.